Jinwoo Bio
Solid Hyaluronic Acid platform for medical devices.
| Date | Investors | Amount | Round |
|---|---|---|---|
* | KRW3.0b | Early VC | |
| Total Funding | 000k | ||
Jinwoo Bio is a South Korean biotechnology company that has commercialized the world's first Solid Hyaluronic Acid Technology Platform (SHTP). Established in May 2013 at the Korea University's Biotechnology Institute's Venture Building in Seoul, the company focuses on developing products for skin beauty, anti-aging, and wound healing.
The company's core innovation, SHTP, addresses the limitations of existing hyaluronic acid products. This technology creates solid forms of hyaluronic acid, such as films, threads, and sheets, without using toxic chemicals, which reduces the risk of side effects like skin necrosis. The platform's versatility allows for applications in pharmaceuticals, medical devices, and cosmetics. In December 2020, Jinwoo Bio relocated its headquarters to Gyeonggi Province, where it established an SHTP manufacturing facility and a research lab. A significant milestone was achieved in March 2022 with the launch of its first medical device, 'JiNu Patch,' a wound dressing utilizing SHTP. The company has secured 15 domestic and 13 overseas patents related to its core technology.
Jinwoo Bio operates with research, production, and development departments, collaborating with specialists in each field to grow into a global biotechnology company. The company has received certifications for its technology, including a New Excellent Technology (NET) approval from the South Korean Ministry of Health and Welfare in August 2021. The business model appears to be centered on the research, development, manufacturing, and sale of medical devices and other products derived from its proprietary SHTP technology, with plans to expand into global markets, including Asia, the US, and Europe.
Keywords: Solid Hyaluronic Acid, SHTP, biotechnology, medical devices, wound healing, anti-aging, skin beauty, pharmaceuticals, cosmetics, hyaluronic acid platform, JiNu Patch, NET certification, Korean bio-venture, medical technology, drug delivery system, tissue engineering, dermatology, aesthetic medicine, regenerative medicine, biomaterials